Literature DB >> 16854501

Polymorphisms and haplotypes in the C-reactive protein gene and risk of dementia.

Marieke van Oijen1, Moniek P M de Maat, Isabella Kardys, Frank Jan de Jong, Albert Hofman, Peter J Koudstaal, Jacqueline C Witteman, Monique M B Breteler.   

Abstract

OBJECTIVE: Inflammation plays a role in the pathogenesis of dementia and Alzheimer's disease (AD). Studies examining serum levels of C-reactive protein in relation to dementia yielded conflicting results. Since serum levels of C-reactive protein are partly determined by genetic factors, we examined the association between genetic variation in the C-reactive protein gene with dementia and AD.
METHODS: This study was performed in the Rotterdam Study, a population-based prospective cohort study among elderly. Polymorphisms in the C-reactive protein gene (1184C>T, 2042C>T and 2911C>G) tagging the common haplotypes were genotyped and haplotypes were constructed. During follow-up (mean 9.2 years) 607 dementia cases were identified. We estimated the association between polymorphisms and haplotypes with dementia and AD with Cox' proportional hazard models.
RESULTS: The T allele of the C-reactive protein 2042C>T polymorphism, related to lower serum levels of C-reactive protein, was associated with a lower risk of dementia and AD. This association was strongest in APOE epsilon4 allele carriers.
CONCLUSION: These findings suggest that C-reactive protein plays a role in development of dementia.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16854501     DOI: 10.1016/j.neurobiolaging.2006.06.015

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  8 in total

1.  Associations of gene sequence variation and serum levels of C-reactive protein and interleukin-6 with Alzheimer's disease and dementia.

Authors:  Ulrika K Eriksson; Nancy L Pedersen; Chandra A Reynolds; Mun-Gwan Hong; Jonathan A Prince; Margaret Gatz; Paul W Dickman; Anna M Bennet
Journal:  J Alzheimers Dis       Date:  2011       Impact factor: 4.472

2.  C-reactive protein and rate of dementia in carriers and non carriers of Apolipoprotein APOE4 genotype.

Authors:  Mary N Haan; Allison E Aiello; Nancy A West; William J Jagust
Journal:  Neurobiol Aging       Date:  2007-05-30       Impact factor: 4.673

3.  Evaluation of inflammation-related genes polymorphisms in Mexican with Alzheimer's disease: a pilot study.

Authors:  Danira Toral-Rios; Diana Franco-Bocanegra; Oscar Rosas-Carrasco; Francisco Mena-Barranco; Rosa Carvajal-García; Marco Antonio Meraz-Ríos; Victoria Campos-Peña
Journal:  Front Cell Neurosci       Date:  2015-05-18       Impact factor: 5.505

4.  C-reactive protein gene variants: independent association with late-life depression and circulating protein levels.

Authors:  M-L Ancelin; A Farré; I Carrière; K Ritchie; I Chaudieu; J Ryan
Journal:  Transl Psychiatry       Date:  2015-01-20       Impact factor: 6.222

5.  Vascular Lesions, APOE ε4, and Tau Pathology in Alzheimer Disease.

Authors:  Jodie B Nichols; Michael Malek-Ahmadi; Pierre N Tariot; Geidy E Serrano; Lucia I Sue; Thomas G Beach
Journal:  J Neuropathol Exp Neurol       Date:  2021-02-22       Impact factor: 3.685

6.  Elevated C-Reactive Protein Is Associated with Cognitive Decline in Outpatients of a General Hospital: The Project in Sado for Total Health (PROST).

Authors:  Yumi Watanabe; Kaori Kitamura; Kazutoshi Nakamura; Kazuhiro Sanpei; Minako Wakasugi; Akio Yokoseki; Osamu Onodera; Takeshi Ikeuchi; Ryozo Kuwano; Takeshi Momotsu; Ichiei Narita; Naoto Endo
Journal:  Dement Geriatr Cogn Dis Extra       Date:  2016-01-19

7.  Oral infections and orofacial pain in Alzheimer's disease: Case report and review.

Authors:  Silvia Regina Dowgan T de Siqueira; Thaís de Souza Rolim; Manoel Jacobsen Teixeira; Ricardo Nitrini; Renato Anghinah; José Tadeu T de Siqueira
Journal:  Dement Neuropsychol       Date:  2010 Apr-Jun

8.  Decreased plasma C-reactive protein levels in APOE ε4 allele carriers.

Authors:  Henna Martiskainen; Mari Takalo; Alina Solomon; Alena Stančáková; Mikael Marttinen; Teemu Natunen; Annakaisa Haapasalo; Sanna-Kaisa Herukka; Johanna Kuusisto; Hilkka Soininen; Miia Kivipelto; Markku Laakso; Mikko Hiltunen
Journal:  Ann Clin Transl Neurol       Date:  2018-09-17       Impact factor: 4.511

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.